Delivery Order SPE2DB20D3103-SPE2DB25FN6F9

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has a ceiling value of $2,237.28 and runs through October 29, 2024. This appears to be a firm fixed-price contract with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,384.80 firm fixed-price contract is for the delivery of 80 mg Telmisartan tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of September 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,329.60 fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has a period of performance through September 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,596.71 firm fixed-price contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,223.72 firm fixed-price contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award has an ultimate completion date of December 10, 2024 and was not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, with a ceiling value of $2,511.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of June 26, 2024 and is a Firm Fixed Price arrangement. This contract is not designated as a set-aside....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Telmisartan 40 mg tablets, a medication used to treat high blood pressure. The contract has a ceiling value of $7,467.44 and is a firm fixed-price, non-set-aside contract type. It has an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 80 mg tablets. The contract has a firm fixed price and does not utilize any set-aside designation, indicating open competition. The total ceiling value of the contract is $1,537.50, with a period of performance through July 5, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has a firm fixed price and a ceiling value of $1,050.38. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,267.80 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of March 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN6F9
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $1,954.81 and a performance period through April 30, 2025.

Additionally, AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:31 AM